Clinical characteristics at enrollment of 51 patients with AL and cardiac involvement
. | No. (%) . | Median (range) . |
---|---|---|
Male | 27 (53) | NA |
Age, years | NA | 63 (28-82) |
Organ involvement | ||
Kidney | 32 (63) | NA |
Autonomic nervous system | 10 (20) | NA |
Liver | 7 (14) | NA |
Peripheral nervous system | 5 (10) | NA |
Soft tissues | 5 (10) | NA |
Gastrointestinal system | 3 (6) | NA |
More than one organ involved | 42 (82) | NA |
Serum creatinine, μM/L | NA | 97.2 (44.2-380.1) |
Creatinine clearance, mL/min | NA | 54 (15-152) |
Proteinuria, g/24 h | NA | 1.4 (0.1-23) |
Monoclonal component type, κ:λ | 12/39 (23/77) | NA |
NT-proBNP concentration, ng/L | NA | 2916 (393-35563) |
Mean left ventricular wall thickness, mm | NA | 16 (12.5-21) |
NYHA class II | 22 (43) | NA |
NYHA class III | 29 (57) | NA |
. | No. (%) . | Median (range) . |
---|---|---|
Male | 27 (53) | NA |
Age, years | NA | 63 (28-82) |
Organ involvement | ||
Kidney | 32 (63) | NA |
Autonomic nervous system | 10 (20) | NA |
Liver | 7 (14) | NA |
Peripheral nervous system | 5 (10) | NA |
Soft tissues | 5 (10) | NA |
Gastrointestinal system | 3 (6) | NA |
More than one organ involved | 42 (82) | NA |
Serum creatinine, μM/L | NA | 97.2 (44.2-380.1) |
Creatinine clearance, mL/min | NA | 54 (15-152) |
Proteinuria, g/24 h | NA | 1.4 (0.1-23) |
Monoclonal component type, κ:λ | 12/39 (23/77) | NA |
NT-proBNP concentration, ng/L | NA | 2916 (393-35563) |
Mean left ventricular wall thickness, mm | NA | 16 (12.5-21) |
NYHA class II | 22 (43) | NA |
NYHA class III | 29 (57) | NA |
NA indicates not applicable.